基本信息
浏览量:75
职业迁徙
个人简介
Research and Clinical Interests
My laboratory is interested in characterizing the role of cytoplasmic signaling pathways in regulation of androgen receptor activity and progression of prostate cancer. Our studies have focused on HER-2 receptor tyrosine kinase and we have demonstrated that HER-2 activation stimulates androgen receptor activity and HER-2 inhibition inhibits androgen receptor transcriptional function at the level of recruitment to the androgen responsive enhancers. These findings have led to the design and initiation of the protocol involving lapatinib, a clinical HER-2 inhibitor, in treatment of patients with prostate cancer. More recently, we have demonstrated that activated Cdc42-associated kinase Ack1 promotes progression of prostate cancer via tyrosine phosphorylation of androgen receptor at Tyr-267 and Tyr-363 residues. We are interested in further characterizing the role of tyrosine phosphorylation of androgen receptor in prostate cancer and development of Ack1 targeted therapy for clinical use.
My laboratory is interested in characterizing the role of cytoplasmic signaling pathways in regulation of androgen receptor activity and progression of prostate cancer. Our studies have focused on HER-2 receptor tyrosine kinase and we have demonstrated that HER-2 activation stimulates androgen receptor activity and HER-2 inhibition inhibits androgen receptor transcriptional function at the level of recruitment to the androgen responsive enhancers. These findings have led to the design and initiation of the protocol involving lapatinib, a clinical HER-2 inhibitor, in treatment of patients with prostate cancer. More recently, we have demonstrated that activated Cdc42-associated kinase Ack1 promotes progression of prostate cancer via tyrosine phosphorylation of androgen receptor at Tyr-267 and Tyr-363 residues. We are interested in further characterizing the role of tyrosine phosphorylation of androgen receptor in prostate cancer and development of Ack1 targeted therapy for clinical use.
研究兴趣
论文共 137 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Emily M. Rencsok,Natalie Slopen, Hannah D. McManus,Karen A. Autio,Alicia K. Morgans, Lawrence McSwain,Pedro Barata,Heather H. Cheng,Robert Dreicer,Travis Gerke, Rebecca Green,Elisabeth I. Heath,
crossref(2024)
Emily M. Rencsok,Natalie Slopen, Hannah D. McManus,Karen A. Autio, Alicia K. Morgans, Lawrence McSwain,Pedro Barata,Heather H. Cheng, Robert Dreicer,Travis Gerke, Rebecca Green,Elisabeth I. Heath,
CANCER RESEARCH COMMUNICATIONSno. 1 (2024): 55-64
The Annals of pharmacotherapypp.10600280231223213-10600280231223213, (2024)
Veda N. Giri,Laura Gross,Rebecca Hartman,Amy Leader,Young E. Whang, Anna Couvillon,Heather H. Cheng,Channing Judith Paller,Stacy Loeb,Lawrence Ivan Karsh, Sue J. Friedman,Tomasz M. Beer,
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationno. 11 (2023): 3209-3221
Journal of Medical Case Reportsno. 1 (2023): 220-5
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 5015-5015
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn